Nuvilex Remains Under Fire While Investors Hold
August 27, 2013 10:10 ET
|
Nuvilex, Inc.
SAN DIEGO, CA--(Marketwired - Aug 27, 2013) - The OTC Journal, the longest running electronic newsletter focused on the small cap and microcap sectors, suggests investors consider the agenda when...
Nuvilex, Inc. Strengthens Its Hand in the Cancer Arena With Purchase of Assets
July 30, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Jul 30, 2013) - Nuvilex, Inc. (OTCQB: NVLX) became a much more valuable company in July when it closed a deal it was fully prepared to pay a great deal more money for,...
Nuvilex, Inc. Moves Closer to Head to Head With Eli Lilly in Phase III Clinical Trials
July 25, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Jul 25, 2013) - Nuvilex, Inc. (OTCQB: NVLX) is currently preparing the way to challenge Eli Lilly's blockbuster cancer drug, Gemzar, and doing so with the knowledge...
Nuvilex, Inc. Acquisition Could Be Steal of the Century and Worth Billions
July 18, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Jul 18, 2013) - In a recently announced acquisition deal, Nuvilex, Inc. (OTCQB: NVLX), pulled off what can only be described as the steal of the century. The company...
Nuvilex, Inc. Returns 100 Million Shares to Company's Treasury After Completing Acquisition
July 16, 2013 09:30 ET
|
Nuvilex, Inc.
SILVER SPRING, MD--(Marketwired - Jul 16, 2013) - Nuvilex, Inc. (OTCQB: NVLX), (the "Company"), an international biotechnology company and provider of natural products and cell and gene therapy...
Nuvilex, Inc. Will Enter Phase III Trials With Advantages Using Cell Encapsulation
July 09, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Jul 9, 2013) - When Nuvilex, Inc. (OTCQB: NVLX) enters its pivotal Phase III clinical trial using its cell encapsulation technology combined with the anti-cancer drug...
Nuvilex, Inc.'s Medical Marijuana Subsidiary Will Be Part of Marijuana Research Boom
June 18, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Jun 18, 2013) - Nuvilex, Inc.'s (OTCQB: NVLX) subsidiary, Medical Marijuana Sciences, Inc., has already declared its focus will be on pancreatic cancer and cancers...